Optimizing Anti-IL17 Antibody Therapy by Associating Fiber Supplementation to Correct Treatment-aggravated Gut Dysbiosis in Axial Spondyloarthritis - RESPOND-IL17
Clinical trial NCT05812157 · COMPLETED
Trial details
- NCT number
- NCT05812157
- Sponsor
- Centre Hospitalier Universitaire de Nīmes
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-02
- Primary completion
- 2026-02-23
- Enrollment
- 76
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.